The technology of MS KOLIBRI is based on the measurement and processing of the data of heart activity (HA) and heart rate variability (HRV) using patented algorithms. Autonomic nervous system (ANS) affects heart activity and controls the work of organs responsible for blood circulation, respiration, digestion, excretion and reproduction, as well as metabolism and growth.
KOLIBRI® system uses autoregressive linear prediction model based on the properties determined from the HA signal for determination of biochemical parameters (Patent US 10,531,836 B2 date: Jan.14, 2020).
Big Data collected from clinical and pre-clinical trials over 9 years has built a base for neural network algorithms, which are expected to be further developed by our industry leading experts in non-invasive medical technologies.
Cloud infrastructure
The device is linked to a cloud infrastructure for remote patient monitoring.
User-friendly interface.
Telemedicine features.
Patient management
In-depth analytics.
Fast notification system.
Research and Development
Further research is being conducted to expand health parameters and additionally identify the following pathological states: diabetes, iron-deficiency anemia, chronic heart failure, myocardial infarction, arterial hypertension, chronic obstructive pulmonary disease, dental status, other.
